Vietnam Enterprise Investments Ltd (LSE:VEIL) reported a 1.7% increase in net asset value for last month as the south-east Asian country’s post-lockdown recovery continued and the stock market saw record highs.
The FTSE 250-listed investment trust saw seven of its top ten holdings rise, with the share price moves for six of the top ten were in a narrow band of 1% change either way for the month, though Saigon Securities Corporation was up 38.2% for the month.
NetScientific PLC (AIM:NSCI), the international life sciences and sustainability technology investment and commercialisation group, has supported the latest financing by Martlet Capital.
The company said its corporate finance and venture capital subsidiary, EMV Capital, syndicated roughly £740,000 of its investment in Martlet Capital to its investor network and invested a further £730,000 or so, which will also be syndicated to its investor network soon.
OKYO Pharma Limited said preclinical research pointed to the ‘potent’ ocular pain-reducing property of its lead drug, OK-101.
The asset is being developed for dry eye disease (DED) and was assessed by Pedram Hamrah, a cornea specialist and clinician-scientist at Tufts Medical Center, Boston.